The EPO published patent application EP3937957A1 filed by OM Pharma SA for a process to manufacture stable bacterial extracts for pharmaceutical use. The application covers compositions classified under IPC codes including A61K 35/74 (bacterial preparations), A61K 39/39 (immunological adjuvants), and C12P 1/04 (microbial processes). The designated states cover all current EPO member states including Germany, France, UK, Italy, Spain, and others.

Patent publications do not create immediate compliance obligations for third parties. However, pharmaceutical companies developing similar bacterial extract technologies should review the application's claims to assess potential freedom-to-operate considerations. Competitors have an opportunity during the examination phase to file observations if they identify prior art or patentability concerns.